Concepedia

Paul Anderson

PA

Statistics

Publications

101

Citations

10.6K

H-Index

47

Active since

1958

Affiliations

United States Military Academy(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Brigham and Women's Hospital

Harvard University

National Cancer Institute

Paul Anderson is an author at United States Military Academy specializing in pharmacology, medicinal chemistry, and medicine.

Publications per year

1958–2023

101

Publications

101

Stress granules and processing bodies are dynamically linked sites of mRNP remodeling

Nancy Kedersha, Georg Stoecklin, Maranatha Ayodele et al. · The Journal of Cell Biology · 2005 · 1.5K citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists

B. Evans, Kenneth E. Rittle, Mark G. Bock et al. · Journal of Medicinal Chemistry · 1988 · 1.4K citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase

Steven D. Young, Susan F. Britcher, L O Tran et al. · Antimicrobial Agents and Chemotherapy · 1995 · 481 citations

Medicine, Pharmacokinetics, Pharmacology +17

Heme-regulated Inhibitor Kinase-mediated Phosphorylation of Eukaryotic Translation Initiation Factor 2 Inhibits Translation, Induces Stress Granule Formation, and Mediates Survival upon Arsenite Exposure

Edward L. McEwen, Nancy Kedersha, Benbo Song et al. · Journal of Biological Chemistry · 2005 · 462 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma.

Hiroshi Nakagomi, Max Petersson, I Magnusson et al. · PubMed · 1993 · 344 citations

Life Sciences, Immunology, Oncology +15

1–5 of 101